The clinical and cost-effectiveness of pulsatile machine perfusion versus cold storage of kidneys for transplantation retrieved from heart-beating and non-heart-beating donors

Health Technology Assessment

Volumn 7, Issue 25, 2003, Pages

  Wight, J ^a   Chilcott, J ^a   Holmes, M ^a   Brewer, N ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN; CYCLOSPORIN A; GLUTATHIONE TRANSFERASE; IMMUNOSUPPRESSIVE AGENT; LYMPHOCYTE ANTIBODY; PREDNISOLONE; STEROID; PRESERVATION SOLUTION;

CALCULATION; CLINICAL TRIAL; COMPARATIVE STUDY; COST EFFECTIVENESS ANALYSIS; COST UTILITY ANALYSIS; CRYOPRESERVATION; DATA BASE; ECONOMIC ASPECT; GRAFT FAILURE; GRAFT SURVIVAL; HEART BEAT; HUMAN; INCIDENCE; KIDNEY DONOR; KIDNEY FAILURE; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY PRESERVATION; KIDNEY TRANSPLANTATION; MACHINE; META ANALYSIS; NONBIOLOGICAL MODEL; PREDICTION; PROBABILITY; REVIEW; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; VALIDATION PROCESS; CELL SURVIVAL; COST BENEFIT ANALYSIS; CYTOLOGY; DONOR; ECONOMICS; GRAFT REJECTION; KIDNEY; METHODOLOGY; ORGAN PRESERVATION; PULSATILE FLOW;

CELL SURVIVAL; COST-BENEFIT ANALYSIS; CRYOPRESERVATION; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; KIDNEY; KIDNEY TRANSPLANTATION; ORGAN PRESERVATION; ORGAN PRESERVATION SOLUTIONS; PULSATILE FLOW; TISSUE DONORS;

EID: 85045797781     PISSN: 13665278     EISSN: None     Source Type: Journal    
DOI: 10.3310/hta7250     Document Type: Review

References (123)

1. Clark EA, Terasaki PI, Opelz G, Mickey MR. Cadaver-kidney transplant failures at one month. N Engl J Med 1974;291:1099-102.
2. Opelz G, Terasaki PI. Kidney preservation: Perfusion versus cold storage - 1975. Transplant Proc 1976;8:121-5.
3. Opelz G, Terasaki PI. Advantage of cold storage over machine perfusion for preservation of cadaver kidneys. Transplantation 1982;33:64-8.
4. Van Der Vliet JA, Vroemen JP, Cohen B, Lansbergen Q, Kootstra G. Preservation of cadaveric kidneys. Cold storage or machine perfusion? Arch Surg 1983;118:1166-8.
5. Ploeg RJ, Van Bockel JH, Langendijk PT, Groenewegen M, Van Der Woude FJ, Persijn GG, et al. Effect of preservation solution on results of cadaveric kidney transplantation. The European Multicentre Study Group. Lancet 1992;340:129-37.
6. Cho YW, Terasaki PI, Cecka JM, Gjertson DW. Transplantation of kidneys from donors whose hearts have stopped beating. N Engl J Med 1998;338:221-5.
7. Cecka JM, Terasaki PI. The UNOS scientific renal transplant registry. Clin Transplant 1995;1-18.
8. Stubenitsky BM, Booster MH, Nederstigt A, Kievit JK, Jacobs RW, Kootstra G. Kidney preservation in the next millennium. Transpl Int 1999;12:83-91.
9. Balupuri S, Strong A, Hoernich N, Snowden C, Mohamed M, Manas D, et al. Machine perfusion for kidneys: How to do it at minimal cost. Transpl Int 2001;14:103-7.
10. Szust J, Olson L, Cravero L. A comparison of OPO pulsatile machine preservation practices and results. J Transpl Coord 1999;9:97-100.
11. Jadad AR, Moore RA, Caroll D, Jenkinson C, Reynolds DJ, Gavaghan DJ, et al. Assessing the quality of clinical trials: Is blinding necessary? Control Clin Trials 1996;17:1-12.
12. Southard JH, D'Alessandro AM. Pulsatile preservation versus static storage for kidney preservation. Curr Opin Organ Transplant 2000;5:237-41.
13. Veller MG, Botha JR, Britz RS, Gecelter GR, Beale PG, Margolius LP, et al. Renal allograft preservation: A comparison of University of Wisconsin solution and of hypothermic continuous pulsatile perfusion. Clin Transplant 1994;8:97-100.
14. Merion RM, Oh HK, Port FK, Toledo-Pereyra LH, Turcotte JG. A prospective controlled trial of cold-storage versus machine-perfusion preservation in cadaveric renal transplantation. Transplantation 1990;50:230-3.
15. Scott DF, Whiteside D, Redhead J, Atkins RC. Ice storage versus perfusion for preservation of kidneys before transplantation. BMJ 1974;4:76-7.
16. Cho SI, Bradley JW, Nabseth DC. Graft survival of perfused vs nonperfused cadaver kidneys. Surg Forum 1975;26:351-2.
17. Barber WH, Deierhoi MH, Phillips MG, Diethelm AG. Preservation by pulsatile perfusion improves early renal allograft function. Transplant Proc 1988;20:865-8.
18. Kumar MS, Samhan M, Al Sabawi N, Al Abdullah IH, Silva OS, White AG, et al. Preservation of cadaveric kidneys longer than 48 hours: Comparison between Euro-Collins solution, UW solution, and machine perfusion. Transplant Proc 1991;23:2392-3.
19. Daemen JH, De Wit RJ, Bronkhorst MW, Marcar ML, Yin M, Heineman E, et al. Short-term outcome of kidney transplants from non-heart-beating donors after preservation by machine perfusion. Transpl Int 1996;9 Suppl 1:S76-80.
20. Balupuri S, Buckley P, Snowdon C, Mustafa M, Sen B, Griffiths P, et al. The trouble with kidneys derived from the non heart beating donor: A single centre 10 year experience. Transplantation 2000;69:842-6.
21. Barry JM, Metcalfe JB, Farnsworth MA, Bennett WM, Hodges CV. Comparison of intracellular flushing and cold storage to machine perfusion for human kidney preservation. J Urol 1980;123:14-16.
22. Sheil AG, Drummond JM, Rogers JH, Boulas J, May J, Storey BG. A controlled clinical trial of machine perfusion of cadaveric donor renal allografts. Lancet 1975;2:287-90.
23. Mittal VK, Toledo-Pereyra LH, Kaplan M, Rosenburg JC, Allaben R. Effect of preservation method on function in the cyclosporine era. Transplant Proc 1985;17:2815-17.
24. Mittal VK, Kaplan MP, Rosenberg JC, Allaben RA, Toledo-Pereyra L. Pulsatile perfusion: Better than hypothermic storage with cyclosporine as an immunosuppressant. Dial Transplant 1985;14:136-40.
25. Light JA, Kowalski AE, Gage F, Callender CO, Sasaki TM. Immediate function and cost comparison between ice storage and pulsatile preservation in kidney recipients in one hospital. Transplant Proc 1995;27:2962-4.
26. Light JA, Gage F, Kowalski AE, Sasaki TM, Callender CO. Immediate function and cost comparison between static and pulsatile preservation in kidney recipients. Clin Transplant 1996;10:233-6.
27. Sellers MT, Gallichi MH, Hudson SL, Young CJ, Bynon JS, Eckhoff DE, et al. Improved outcomes in cadaveric renal allografts with pulsatile preservation. Clin Transplant 2000;14:543-9.
28. Polyak MM, Arrington BO, Stubenbord WT, Boykin J, Brown T, Jean-Jacques MA, et al. The influence of pulsatile preservation on renal transplantation in the 1990s. Transplantation 2000;69:249-58.
29. Sanfilippo F, Vaughn WK, Spees EK, Lucas BP. The detrimental effects of delayed graft function in cadaver donor renal transplantation. Transplantation 1984;38:643-8.
30. Spees EK, Vaughn WK, Mendez-Picon G, Humphries AL. Preservation methods do not affect cadaver renal allograft outcome: The SEPPF prospective study 1977-1982. Transplantat Proc 1984;16:177-9.
31. Van Der Vliet JA, Vroemen S, Cohen B, Kootstra G. Comparison of cadaver kidney preservation methods in Eurotransplant. Transplantat Proc 1984;16:180-1.
32. Peters TG, Shaver TR, Ames JE, Santiago-Delphin EA, Jones KW, Blanton JW. Cold ischaemia and outcome in 17,937 cadaveric kidney transplants. Transplantation 1995;59:191-6.
33. Halloran P, Aprile M. A randomized prospective trial of cold storage versus pulsatile perfusion for cadaver kidney preservation. Transplantation 1987;43:827-32.
34. Jaffers GJ, Banowsky LH. The absence of a deleterious effect of mechanical kidney preservation in the era of cyclosporine. Transplantation 1989;47:734-6.
35. Mozes MF, Finch W, Reckard CR, Merkel FK, Cohen C. Comparison of cold storage and machine perfusion in the preservation of cadaver kidneys: A prospective, randomized study. Transplant Proc 1985;17:1474-7.
36. Heil JE, Canafax DM, Sutherland DE, Simmons RL, Dunning M, Najarian JS. A controlled comparison of kidney preservation by two methods: Machine perfusion and cold storage. Transplant Proc 1987;19:2046.
37. Matsuno N, Sakurai E, Tamaki I, Uchiyama M, Kozaki K, Kozaki M. The effect of machine perfusion preservation versus cold storage on the function of kidneys from non-heart-beating donors. Transplantation 1994;57:293-4.
38. Alijani MR, Cutler J, DelValle CJ, Morres DN, Fawzy A, Pechan BW, et al. Single-donor cold storage versus machine perfusion in cadaver kidney preservation. Transplantation 1985;40:659-61.
39. Marshall VC, Ross H, Scot DF, McInnes S, Thomson N, Atkins RC, et al. Preservation of cadaver of renal allografts: Comparison of ice storage and machine perfusion. Med J Aust 1977;2:353-6.
40. Marshall VC, Ross H, Scott DF, McInnes S, Thomson N, Atkins RC. Preservation of cadaveric renal allografts-comparison of flushing and pumping techniques. Proc Eur Dial Transplant Assoc 1977;14:302-9.
41. Marshall VC. Renal preservation prior to transplantation. Transplantation 1980;30:165-6.
42. Matsuno N, Kozaki M, Sakurai E, Uchiyama M, Iwahori T, Kozaki K, et al. Effect of combination in situ cooling and machine perfusion preservation on non-heart beating donor kidney procurement. Transplant Proc 1999;25:1516-17.
43. Matsuno N, Sakurai E, Uchiyama M, Kozaki K, Tamaki I, Kozaki M. Use of in situ cooling and machine perfusion preservation for non-heart-beating donors. Transplant Proc 1993;25:3095-6.
44. Sterling WA, Pierce JC, Hutcher NE, Lee HM, Hume DM. A comparison of hypothermic preservation with hypothermic pulsatile perfusion in paired human kidneys. Surg Forum 1971;22:229-30.
45. Beck TA. Machine versus cold storage preservation and TAN versus the energy charge as a predictor of graft function posttransplantation. Transplant Proc 1979;11:459-64.
46. Toledo-Pereyra LH. Renal hypothermic storage with a new hyperosmolar colloid solution. Bol Assoc Med PR 1983;75:347-50.
47. Rosenthal J, Herman JB, Taylo RJ, Broznick B, Hakala TR. Comparison of pulsatile machine perfusion with cold storage for cadaver kidney preservation. Transplantation 1984;37:425-6.
48. Mendez R, Mendez RG, Koussa N, Cats S, Bogaar TP, Khetan U. Preservation effect on oligo-anuria in the cyclosporine era: A prospective trial with 26 paired cadaveric renal allografts. Transplant Proc 1987;19:2047-50.
49. Gage F, Ali M, Alijani MR, Aquino AO, Barhyte DY, Callender CO, et al. Comparison of static versus pulsatile preservation of matched-paired kidneys. Transplant Proc 1997;29:3644-5.
50. Kosieradzki M, Danielewic R, Kwiatkowski A, Polak W, Wegrowicz-Rebandel I, Walaszewski J, et al. Rejection rate and incidence of acute tubular necrosis after pulsatile perfusion preservation. Transplant Proc 1999;31:278-9.
51. Van Der Vliet JA, Kievit JK, Hene RJ, Hilbrands LB, Kootstra G. Preservation of non-heart-beating donor kidneys: A clinical prospective randomised case-control study of machine perfusion versus cold storage. Transplant Proc 2001;33:847.
52. Baxby K, Taylor RM, Anderson M, Johnson RW, Swinney J. Assessment of cadaveric kidneys for transplantation. Lancet 1974;2:977-9.
53. Sampson D, Kauffman HM, Peters T, Walczak P. Perfusion characteristics and transplant function in machine-preserved kidneys. Transplant Proc 1977;9:1551-2.
54. Sampson D, Jun HM, Walczak P. Flow and function in machine-preserved kidneys. Br J Surg 1978;65:37-40.
55. Burleson RL, Jones DB, Yenikomshian AM, Cornwall C, DeVoe C, DeRito J. Clinical renal preservation by cryoperfusion with an albumin perfusate: Renal perfusion with albumin. Arch Surg 1978;113:688-92.
56. Fienfeld DA, Levine RD, Levine SD, Fleischner G. Ligandin in perfusates from transplanted kidneys: A test for tubular necrosis. Nephron 1978;21:38-41.
57. Horpacsy G, Schroder K, Zinsmeyer J, Althaus P, May G, Mebel M. Clinical experiences in the Gambro-preservation unit: Analysis of 105 human cadaver kidneys. Acta Med Pol 1978;19:59-65.
58. Horpacsy G, Scholz D, Althaus P, May G. Clinical experiences in the Gambro-preservation unit: Analysis of 101 human cadaver kidneys. Eur Surg Res 1979;11:50-60.
59. Sy G, Toledo-Pereyra L, Dienst S, Oh HK. Are there any important predicting factors of renal function during hypothermic pulsatile perfusion for transplantation? Am Surg 1980;46:340-3.
60. Cho SI, Zalneraitis B, Ohmi N, Arias IM. Prediction of cadaver kidney function by ligandin analysis. J Surg Res 1981;30:361-4.
61. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Pulsatile kidney perfusion for preservation and evaluation: Use of high-risk kidney donors to expand the donor pool. Transplant Proc 1993;25:3099-100.
62. Tesi RJ, Elkhammas EA, Davies EA, Henry ML, Ferguson RM. Pulsatile kidney perfusion for evaluation of high-risk kidney donors safely expands the donor pool. Clin Transplant 1994;8:134-8.
63. Daemen JH, Heineman E, Kootstra G. Viability assessment of non-heart-beating donor kidneys during machine preservation. Transplant Proc 1995;27:2906-7.
64. Matsuno N, Sakurai E, Tamaki I, Furuhashi K, Saito A, Zhang S, et al. Effectiveness of machine perfusion preservation as a viability determination method for kidneys procured from non-heart-beating donors. Transplant Proc 1994;26:2421-2.
65. Matsuno N, Sakurai E, Uchiyama M, Kozaki K, Miyamoto K, Kozaki M. Usefulness of machine perfusion preservation for non-heart-beating donors in kidney transplantation. Transplant Proc 1996;28:1551-2.
66. Matsuno N, Sakurai E, Uchiyama M, Kozaki K, Miyamoto K, Kozaki M, Nagao T. Role of machine perfusion preservation in kidney transplantation from non-heartbeating donors. Clin Transplant 1998;12:1-4.
67. Polyak M, Boykin J, Arrington B, Stubenbord WT, Kinkhabwala M. Pulsatile preservation characteristics predict early graft function in extended criteria donor kidneys. Transplant Proc 1997;29:3582-3.
68. Polyak MM, Arrington B, Hardy MA, Stubenbord WT, Kinkhabwala M. The state of renal preservation for transplantation in New York. Transplant Proc 1999;31:2091-3.
69. Danielewicz R, Kwiatkowski A, Polak W, Kosieradzki M, Michalak G, Wegrowicz I, et al. An assessment of ischemic injury of the kidney for transplantation during machine pulsatile preservation. Transplant Proc 1997;29:3580-1.
70. Kievit JK, Nederstigt AP, Oomen AP, Janssen MA, Schoot L, Kootstra G. Release of alpha-glutathione S-transferase (alpha GST) and pi-glutathione S-transferase (pi GST) from ischemic damaged kidneys into the machine perfusate - Relevance to viability assessment. Transplant Proc 1997;29:3591-3.
71. Kievit JK, Oomen AP, Janssen MA, Van Kreel BK, Heineman E, Kootstra G. Viability assessment of non-heart-beating donor kidneys by alpha glutathione S-transferase in the machine perfusate. Transplant Proc 1997;29:1381-3.
72. Balupuri S, Buckley P, Mohamed M, Cornell C, Mantle D, Kirby J, et al. Assessment of non-heart-beating donor (NHBD) kidneys for viability on machine perfusion. Clin Chem Lab Med 2000; 38: 1103-6.
73. Balupuri S, Buckley P, Mohamad M, Chidambaram V, Gerstenkorn C, Sen B, et al. Early results of a non-heartbeating donor (NHBD) programme with machine perfusion. Transpl Int 2000;13 Suppl 1:S255-8.
74. Matsuno N, Kozaki K, Degawa H, Narumi Y, Suzuki N, Kikuchi K, et al. Importance of machine perfusion flow in kidney preservation. Transplant Proc 1999;31:2004-5.
75. Matsuno N, Kozaki K, Degawa H, Narumi Y, Suzuki N, Kikuchi K, et al. A useful predictor in machine perfusion preservation for kidney transplantation from non-heart-beating donors. Transplant Proc 2000;32:173-4.
76. Kozaki K, Sakurai E, Kubota K, Iwamot, H, Hama K, Narumi Y, et al. Prediction of kidney nonfunction after transplantation with machine perfusion preservation. Transplant Proc 2000;32:275-6.
77. Kwiatkowski A, Danielewicz R, Kosieradzki M, Polak WP, Wszola M, Fesolowicz S, et al. Six-year experience in continuous hypothermic pulsatile perfusion kidney preservation. Transplant Proc 2001;33:1-2.
78. Johnson CP, Roza AM, Adams MB. Local procurement with pulsatile perfusion gives excellent results and minimizes initial cost associated with renal transplantation. Transplant Proc 1990;22:385-7.
79. Cecka JM, Terasaki P. The UNOS Scientific Renal Transplant Registry - 1990. Clin Transplant 1990;1-10.
80. Kato M, Mizutani K, Hattori R, Kinukawa T, Uchida K, Hoshinaga K, et al. In situ renal cooling for kidney transplantation from non-heart-beating donors. Transplant Proc 2000;32:1608-10.
81. Halloran PF, Aprile MA, Farewell V, Ludwin D, Smith EK, Tsai SY, et al. Early function as the principal correlate of graft survival. A multivariate analysis of 200 cadaveric renal transplants treated with a protocol incorporating antilymphocyte globulin and cyclosporine. Transplantation 1988;46:223-8.
82. Cole E, Naimark D, Aprile M, Wade J, Cattran D, Pei Y, et al. An analysis of predictors of long-term cadaveric renal allograft survival. Clin Transplant 1995;9:282-8.
83. Balupuri S, Mantle D, Mohamed M, Shenton B, Gok M, Soomro N, et al. Machine perfusion and viability assessment of non-heart-beating donor kidneys - A single-centre result. Transplant Proc 2001;33:1119-20.
84. Feldman HI, Gayner R, Berlin JA, Roth DA, Silibovski R, Kushner S, et al. Delayed function reduces renal allograft survival independent of acute rejection. Nephrol Dial Transplant 1996;11:1306-13.
85. Raikou M, Gray A, Briggs A, Stevens R, Cull C, McGuire A,et al. Cost effectiveness analysis of improved blood pressure control in hypertensive patients with type 2 diabetes: UKPDS 40. BMJ 1998;317:720-5.
86. Moore R. Cost effective use of immunosuppression in a world of finite health resources. International Congress and Symposium Series 217. London: Royal Society of Medicine Press; 1997.
87. Meechan D, Jones R, Payne N. Utilisation of Renal Replacement Therapy. Trent Public Health Observatory; 2001.
88. Chilcott J, Corcoran M, Rigg K M, Burden RP. Tacrolimus and Mycophenolate Mofetil as Maintenance Immunosuppressants Following Renal Transplantation. Trent Institute for Health Services Research. Guidance Note for Purchasers: 99/07; 1999.
89. UK medicines information service. URL: http://www.ukmi.nhs.uk; 2002.
90. Hornberger JC, Best JH, Garrison LP. Cost-effectiveness of repeat medical procedures: Kidney transplantation as an example. Med Decis Making 1997;17:363-72.
91. Burdick J, Rosendale JD, McBride MA, Kauffman HM, Bennett LE. National impact of pulsatile perfusion on cadaveric kidney transplantation. Transplantation 1997;64:1730-3.
92. Whittaker JR, Veith FJ, Soberman R. The fate of the renal transplant with delayed function. Surg Gynecol Obstet 1973;136:919-22.
93. Opelz G, Sasaki N, Terasaki PI. Prediction of long term kidney transplant survival rates by monitoring early graft function and clinical grades. Transplantation 1978;25:212-15.
94. Sanfilippo F, Vaughn WK, LeFor WN, Spees EK. Multivariate analysis of risk factors in cadaver donor kidney transplantation. Transplantation 1986;42:28-34.
95. Canafax DM, Torres A, Fryd DS, Heil JE, Strand MH, Ascher NL, et al. The effects of delayed function on recipients of cadaver renal allografts. A study of 158 patients randomized to cyclosporine or ALG-azathioprine. Transplantation 1986;41:177-81.
96. Belitsky P, MacDonald A, Gajewski J, Boudreau J, Bitter-Suermann H, Cohen A. Significance of delayed function in cyclosporine-treated cadaver kidney transplants. Transplant Proc 1987;19:2096-9.
97. Lim EC, Terasaki PI. Early graft function. Clin Transplant 1991;401-7.
98. Cecka JM, Cho YW, Terasaki PI. Analyses of the UNOS Scientific Renal Transplant Registry at three years - Early events affecting transplant success. Transplantation 1992;53:59-64.
99. Cacciarelli T, Sumrani M, Delaney V, Hong JH. The influence of delayed renal allograft function on long term outcome in the cyclosporine era. Clin Nephrol 1993;39:335-9.
100. Yokoyama I, Uchica K, Kobayashi T, Tominaga Y, Orihara A, Takagi H. Effect of prolonged delayed graft function on long term graft outcome in cadaveric kidney transplantation. Clin Transplant 1994;8:101-6.
101. Troppmann C, Gillingham KJ, Benedetti E, Almond PS, Gruessner RWG, Najarian JS and Matas AJ. Delayed graft function, acute rejection, and outcome after cadaver renal transplantation. Transplantation 1995;59:962-8.
102. Shoskes DA, Avelino L, Barba L, Sender M. Patient death or renal graft loss within 3 years of transplantation in a county hospital: Importance of poor initial graft function. Clin Transplant 1997;11:618-22.
103. Ojo AO, Wolfe RA, Held PJ, Port FK, Schmouder RL. Delayed graft function: Risk factors and implications for renal allograft survival. Transplantation 1997;63:968-74.
104. Lehtonen SRK, Isoniemi HM, Salmela KT, Taskinen EI, Von Willebrand EO and Ahonen JP. Long-term graft outcome is not necessarily affected by delayed onset of graft function and early acute rejection. Transplantation 1997;64:103-7
105. Clark EA, Opelz G, Mickey MR, Terasaki PI. Evaluation of Belzer and Collins kidney-preservation methods. Lancet 1973;1:361-364
106. Claes G, Blohme I, Stenberg K. Kidney preservation by continuous hypothermic albumin perfusion without membrane oxygenation. Proc Eur Dial Transplant Assoc 1976;12:483-91.
107. Collins GM, Jones AC, Halasz NA. Influence of preservation method on early transplant failure. Transplant Proc 1977;9:1523-8.
108. Light JA, Annable CA, Spees EK, Jr. Oakes DD, Flye MW, Reinmuth B. Comparison of long-term kidney survival following cold storage or pulsatile preservation. Transplant Proc 1977;9:1517-19.
109. Slooff MJ, Van Der Wijk J, Rijkmans BG, Kootstra G. Machine perfusion versus cold storage for preservation of kidneys before transplantation. Arch Chir Neerland 1978;30:83-90.
110. Johnson HK, Fleming C, Warner H, VonSchmittou E, Tallent M, Niblack G, et al. The relation of graft survival to preservation method and kidney sharing. Transplant Proc 1977;9:1513-16.
111. Collins GM, Halasz NA. Clinical comparison of methods for cadaveric kidney preservation. J Surg Res 1978;24:396-400.
112. Van Der Vliet JA, Slooff MJH, Rijkmans BG, Kootstra G. Use of non-heart-beating donor kidneys for transplantation. Eur Surg Res 1981;13:354-60.
113. Vaughn WK, Mendez-Picon G, Humphries AL, Spees EK. Method of preservation is not a determinant of graft outcome in kidneys transplanted by Southeastern Organ Procurement Foundations Institutions. Transplantation 1981;32:490-4.
114. Manis T, Hong JH, Bronsther OL, Friedmann EA, Butt KM. Superior results with machine-perfused kidneys in cyclosporine-treated transplant recipients. Transplant Proc 1985;17:1483-4.
115. Nghiem DD, Schulak JA, Corry RJ. Cadaver kidney preservation beyond 40 hours: Superiority of machine preservation over cold storage. Transplant Proc 1986;18:564-5.
116. Abouna GM, Samhan MS, Kumar MS, White AG, Silva OS. Limiting factors in successful preservation of cadaveric kidneys with ischemia time exceeding 50 hours. Transplant Proc 1987;19:2051-5.
117. Barber WH, Hudson SL, Deierhoi MH, Laskow DA, Diethelm AG. Pulsatile perfusion preservation: Early posttransplant dialysis requirement predicts rapid graft loss. Transplant Proc 1990;22:446-7.
118. Barber WH, Laskow DA, Deierhoi MH, Poplawski SC, Diethelm AG. Comparison of simple hypothermic storage, pulsatile perfusion with belzer gluconate-albumin solution, and pulsatile perfusion with UW solution for renal-allograft preservation. Transplant Proc 1991;23:2394-5.
119. Zhou YC, Cecka JM. Preservation. Clin Transplants 1992;383-90.
120. Koyama H, Cecka JM, Terasaki P. A comparison of cadaver donor kidney storage methods: Pump perfusion and cold storage solutions. Clin Transplant 1993;7:199-205.
121. Daemen JH, De Vries B, Oomen AP, DeMeester J, Kootstra G. Effect of machine perfusion preservation on delayed graft function in non-heart-beating donor kidneys - Early results. Transpl Int 1997;10:317-22.
122. Daemen JH, De Vries B, Kootstra G. The effect of machine perfusion preservation on early function of non-heart-beating donor kidneys. Transplant Proc 1997;29:3489.
123. Polyak MM, Arrington BO, Kapur S, Stubenbord WT, Kinkhabwala M. Donor treatment with phentolamine mesylate improves machine preservation dynamics and early renal allograft function. Transplantation 2000;69:184-6.